Table 2.
Mean values ± standard deviation (median values) recorded before the race.
| CT (sec) | CFT (sec) | MCF (mm) | α (°) | Vmax (mm/min) | AUC (mm2) | ||
|---|---|---|---|---|---|---|---|
| EXT | NC | 56.7 ± 14.6 | 140.±19.3 | 54.4 ± 5.0 | 68.0 ± 5.4 | 12.3 ± 2.5 | 5420.1 ± 498.6 |
| (59.0) | (140.0) | (54.0) | (70.0) | (11.0) | (5358.0) | ||
| E | 49.9 ± 4.6 | 122.7 ± 24.1 | 57.8 ± 4.5 | 71.7 ± 5.0 | 14.7 ± 4.1 | 5754.0 ± 411.3 | |
| (48.4) | (127.8) | (57.6) | (70.5) | (14.1) | (5739.3) | ||
| INT | NC | 277.0 ± 37.5 | 124.1 ± 22.5 | 47.0 ± 5.8 | 66.1 ± 3.7 | 12.1 ± 6.0 | 4739.0 ± 587.8 |
| (287.0) | (124.0) | (45.0) | (66.0) | (10.0) | (4595.0) | ||
| E | 291.1 ± 33.5 | 100.6 ± 12.5 | 50.3 ± 4.4 | 69.9 ± 1.7 | 14.0 ± 3.9 | 4965.4 ± 418.2 | |
| (294.3) | (102.2) | (49.8) | (69.8) | (12.8) | (4871.2) | ||
| FIB† | NC | 51.0 ± 4.5 | Nd | 15.3 ± 3.3 | 70.7 ± 6.9 | 14.6 ± 2.7 | 1504.0 ± 329.2 |
| (51.0) | (15.0) | (72.0) | (14.0) | (1485.0) | |||
| E | 47.4 ± 3.2 | Nd | 16.9 ± 3.4 | 75.2 ± 2.7 | 17.0 ± 3.6 | 1673.6 ± 368.5 | |
| (47.5) | (16.5) | (74.0) | (16.0) | (1623.0) | |||
| LYS† | NC | 50.5 ± 3.4 | 162.0 ± 22.5 | 48.7 ± 3.1 | 65.8 ± 7.0 | 11.2 ± 2.6 | 4825.8 ± 297.6 |
| (50.5) | (165.5) | (48.5) | (67.5) | (12.0) | (4783.5) | ||
| E | 52.6 ± 5.7 | 142.9 ± 31.6 | 53.8 ± 4.2 | 67.3 ± 7.7 | 14.0 ± 3.8 | 5345.4 ± 483.0 | |
| (53.5) | (140.0) | (53.5) | (66.0) | (13.5) | (5305.0) |
NC: negative controls; E: EIPH; EXT: extrinsic pathway; INT: intrinsic pathway; FIB: fibrinogen activity; LYS: fibrinolysis; nd: not determinable; in bold P < .05 versus the pre-race NC value; † Fibrinogen and fibrinolytic activities were determined in only 11 samples.